Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans

• 收藏
• 分享

专利权人:

发明人:

Harry M. Lander,David R. Koos

申请号：

US15820324

公开号：

US20180214413A1

申请日:

2017.11.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein to humans.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/